Features:
- Unique carrier or excipient free ULTRAFREE Coating technology effectively controls Paclitaxel crystallization process resulting in a uniform and stable microcrystal drug coating
- Avert B has uniform coating of 3 µg/mm2 using integrated ULTRAFREE coating Technology which prevents drug flaking during procedure preparation and device tracking
- Effective drug tissue concentration of the lesion site lasts more than 90 days
- Avert B DCB is available in 0.014”,0.018”,0.035” balloon catheter platforms and available in lengths of 40,60,80,100,120,150 and 220mm